Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,356,356 papers from all fields of science
Search
Sign In
Create Free Account
3,4-dihydroxyphenylacetaldehyde
Known as:
DHPAA aldehyde
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
3,4-Dihydroxyphenylacetic Acid
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
Y. Jinsmaa
,
R. Isonaka
,
Y. Sharabi
,
D. Goldstein
Journal of Pharmacology and Experimental…
2019
Corpus ID: 208186621
Lewy body diseases such as Parkinson’s disease involve intraneuronal deposition of the protein α-synuclein (AS) and depletion of…
Expand
Highly Cited
2014
Highly Cited
2014
Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
Ching-Chi Chiu
,
T. Yeh
,
+9 authors
C. Lu
Experimental Neurology
2014
Corpus ID: 15845373
Review
2013
Review
2013
Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease.
D. Goldstein
Advances in Pharmacology
2013
Corpus ID: 3434621
Highly Cited
2012
Highly Cited
2012
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease
D. Goldstein
,
P. Sullivan
,
+6 authors
Y. Sharabi
Journal of Neurochemistry
2012
Corpus ID: 13780657
Parkinson's disease entails profound loss of nigrostriatal dopaminergic terminals, decreased vesicular uptake of intraneuronal…
Expand
2011
2011
Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.
Y. Jinsmaa
,
Virginia R. Florang
,
+5 authors
J. Doorn
Chemico-Biological Interactions
2011
Corpus ID: 10621346
Highly Cited
2000
Highly Cited
2000
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4‐dihydroxyphenylacetaldehyde
I. Lamensdorf
,
G. Eisenhofer
,
J. Harvey‐White
,
Y. Hayakawa
,
K. Kirk
,
I. Kopin
Journal of Neuroscience Research
2000
Corpus ID: 19156114
3,4‐Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidative‐deamination of…
Expand
Highly Cited
1991
Highly Cited
1991
Human aldehyde dehydrogenase. Activity with aldehyde metabolites of monoamines, diamines, and polyamines.
W. Ambroziak
,
R. Pietruszko
Journal of Biological Chemistry
1991
Corpus ID: 35959646
Highly Cited
1988
Highly Cited
1988
Human brain "high Km" aldehyde dehydrogenase: purification, characterization, and identification as NAD+ -dependent succinic semialdehyde dehydrogenase.
M. T. Ryzlak
,
R. Pietruszko
Archives of Biochemistry and Biophysics
1988
Corpus ID: 43457181
Highly Cited
1986
Highly Cited
1986
Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
P. Yu
,
B. A. Bailey
,
D. Durden
,
A. Boulton
Biochemical Pharmacology
1986
Corpus ID: 13276535
Highly Cited
1977
Highly Cited
1977
Decarboxylation-dependent transamination catalyzed by mammalian 3,4-dihydroxyphenylalanine decarboxylase.
M. O'Leary
,
R. L. Baughn
Journal of Biological Chemistry
1977
Corpus ID: 21829003
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE